Pandemic Perspectives: ‘No Pandemic-Driven Slowdown’ According To Simon-Kucher & Partners

In a discussion with Medtech Insight, partners at Simon-Kucher & Partners explained that the pandemic has, and will continue to, transform both the sales and revenue models of medtech.

The COVID-19 pandemic wrought effects on global markets throughout 2020, and into 2021, with companies struggling to perform business as they usually would.

Despite this, medtech companies fared better than many other major sectors. According to Simon-Kucher & Partners’ 2021 Global Pricing Study,...